Kazia Therapeutics Limited Revenue per Employee (KZIA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kazia Therapeutics Limited  (NASDAQ: KZIA)
 

Kazia Therapeutics Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Kazia Therapeutics Limited's Revenue per employee grew on a trailing twelve month basis to $ 894, above the company average.
Within the Healthcare sector Employees of 528 other companies have achieved higher revenue per employee. While Kazia Therapeutics Limited's total ranking has deteriorated compared to the previous quarter from 3139 to 3546. Kazia Therapeutics Limited has 47 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KZIA Revenue per Employee (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Revenue Change -98.31 % - - - 248000 %
Sales per Employee (TTM) $ 894 52,787 52,787 52,787 52,787
KZIA's Total Ranking # 3546 # 3139 # # #
Seq. Revenue Change - - - - -

KZIA Company Profile >> Back to KZIA Efficiency Comparisons >> Compare KZIA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 189
Healthcare Sector # 529
Overall Market # 3546

Revenue per Employee Statistics
High Average Low
$ 323,085 $ 88,569 $ 21
(Jun 30 2021)   (Jun 30 2023)



Financial Statements
Kazia Therapeutics Limited's Revenue MRQ $ 0 Millions Visit KZIA's Income Statement
Kazia Therapeutics Limited's Revenues TTM $ 0 Millions Visit KZIA's aggregate revenue growth
What are KZIA's Sales? Visit KZIA's Sales by Segment




Other Ratios
Kazia Therapeutics Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KZIA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KZIA's Competitors
Revenue per Employee for KZIA's Suppliers
Revenue per Employee for KZIA's Customers

You may also want to know
KZIA's Sales Growth Rates KZIA's Pe Price to earnings ratio KZIA's Receivables Turnover Ratio KZIA's Stock Quote
KZIA's Net Income Growth Rates KZIA's Ps Price to Sales ratio KZIA's Sales per Employee KZIA's Asset Turnover Ratio
KZIA's Net Margin KZIA's Pb Price to Book ratio KZIA's Financial Strength Ratios KZIA's Dividend Payout Ratio
Date modified: 2026-07-07T11:49:03+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Sera Prognostics Inc   1,500.00 $ 0.108  Million 72 
Cardio Diagnostics Holdings Inc   1,147.47 $ 0.020  Million 17 
Kazia Therapeutics Limited  893.62 $ 0.042  Million 47 
Aditxt Inc   461.54 $ 0.012  Million 26 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.